<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03230214</url>
  </required_header>
  <id_info>
    <org_study_id>020583</org_study_id>
    <nct_id>NCT03230214</nct_id>
  </id_info>
  <brief_title>Effect of Bacterial Translocation on Haemodynamic and Coagulation Parameters During Liver Transplantation</brief_title>
  <official_title>Effect of Bacterial Translocation on Haemodynamic and Coagulation Parameters During a Liver Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alexandria University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alexandria University</source>
  <brief_summary>
    <textblock>
      The present study is to demonstrate the effect of the presence of bacterial translocation
      detected by bacterial deoxyribonucleic acid (bactDNA) in blood and ascites using the
      polymerase chain reaction (PCR) on some haemodynamic and coagulation parameters during a
      liver transplant procedure.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 3, 2017</start_date>
  <completion_date type="Actual">November 14, 2017</completion_date>
  <primary_completion_date type="Actual">October 24, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>change in the mean arterial blood pressure</measure>
    <time_frame>at the beginning of surgery then 15 nim after dissection then 15 min after the anhepatic phase then 15 min at the reperfusion phase</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>antifactor X activity</measure>
    <time_frame>at the beginning of surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>change in the heart rate</measure>
    <time_frame>at the beginning of surgery then 15 nim after dissection then 15 min after the anhepatic phase then 15 min at the reperfusion phase</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>change in the cardiac output</measure>
    <time_frame>at the beginning of surgery then 15 nim after dissection then 15 min after the anhepatic phase then 15 min at the reperfusion phase</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Effect of Bacterial Translocation</condition>
  <arm_group>
    <arm_group_label>DNA positive patients</arm_group_label>
    <description>patients who have bacterial DNA in their samples</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DNA negative patients</arm_group_label>
    <description>patients who do not have bacterial DNA in their samples</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>PCR for bacterial translocation</intervention_name>
    <description>samples taken from the blood and ascites of patients to search for bacterial DNA</description>
    <arm_group_label>DNA positive patients</arm_group_label>
    <arm_group_label>DNA negative patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        adult patients with grade C liver cirrhosis with liver failure undergoing liver
        transplantation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        • patients with liver failure undergoing liver transplantation

        Exclusion Criteria:

          -  Age less than 18 years;

          -  Active overt infection;

          -  Patients on oral or systemic anticoagulation or with known coagulopathic disorders
             apart from those caused by liver failure (eg.: Protein C or S deficiency, congenital
             platelet disorders and congenital coagulation disorders…etc);

          -  Patients undergoing re-transplantation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>ahmed mukhtar, MD</last_name>
    <role>Study Director</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Elmoasah Hospital</name>
      <address>
        <city>Alexandria</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 20, 2017</study_first_submitted>
  <study_first_submitted_qc>July 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2017</study_first_posted>
  <last_update_submitted>January 13, 2018</last_update_submitted>
  <last_update_submitted_qc>January 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Alexandria University</investigator_affiliation>
    <investigator_full_name>Heba Moharem</investigator_full_name>
    <investigator_title>assisstant lecturer</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

